BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35175571)

  • 1. The first case of SMARCA4-deficient sarcoma of stomach.
    Ota T; Ishikawa T; Yasuda R; Yasuda T; Okayama T; Inoue K; Dohi O; Yoshida N; Kamada K; Uchiyama K; Takagi T; Konishi H; Naito Y; Matsuyama K; Yamaguchi T; Ootsuka K; Yoshida A; Kishimoto M; Itoh Y
    Clin J Gastroenterol; 2022 Jun; 15(3):531-536. PubMed ID: 35175571
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Nakra T; Kakkar A; Mathur SR; Jain D; Kumar S
    Int J Surg Pathol; 2023 Feb; 31(1):104-109. PubMed ID: 35466749
    [No Abstract]   [Full Text] [Related]  

  • 3. Pathological characteristics and immune microenvironment of SMARCA4-deficient undifferentiated uterine sarcoma.
    Gao J; Fan R; Chen D; Hou J; Chen H; Lu M
    Diagn Pathol; 2023 May; 18(1):62. PubMed ID: 37194064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SMARCA4-deficient thoracic sarcoma: report of a case and insights into how to reach the diagnosis using limited samples and resources.
    Kuwamoto S; Matsushita M; Takeda K; Tanaka N; Endo Y; Yamasaki A; Kohashi K; Oda Y; Horie Y
    Hum Pathol; 2017 Dec; 70():92-97. PubMed ID: 28601660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous metastasis of SMARCA4-deficient thoracic sarcoma: A diagnostic dilemma with therapeutic implications.
    Leckey BD; Selim MA; Al-Rohil RN
    J Cutan Pathol; 2020 Jun; 47(6):561-565. PubMed ID: 31995235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atezolizumab with bevacizumab, paclitaxel and carboplatin was effective for patients with SMARCA4-deficient thoracic sarcoma.
    Kawachi H; Kunimasa K; Kukita Y; Nakamura H; Honma K; Kawamura T; Inoue T; Tamiya M; Kuhara H; Nishino K; Mizote Y; Akazawa T; Tahara H; Kumagai T
    Immunotherapy; 2021 Jul; 13(10):799-806. PubMed ID: 34030451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SMARCA4-deficient thoracic sarcoma revealed by metastasis to the small intestine: a diagnostic dilemma.
    Khanchel F; Hedhili R; Zenaidi H; Helal I; Yahmadi A; Ben Néji H; Ksontini F; Ben Brahim E; Jouini R; Chadli A
    Gen Thorac Cardiovasc Surg; 2021 Jul; 69(7):1155-1158. PubMed ID: 33866513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytologic Features of SMARCA4-Deficient Thoracic Sarcoma: A Case Report and Comparison with Other SWI/SNF Complex-Deficient Tumors.
    Matsushita M; Kuwamoto S
    Acta Cytol; 2018; 62(5-6):456-462. PubMed ID: 30286456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SMARCA4-deficient Thoracic Sarcomas: Clinicopathologic Study of 30 Cases With an Emphasis on Their Nosology and Differential Diagnoses.
    Perret R; Chalabreysse L; Watson S; Serre I; Garcia S; Forest F; Yvorel V; Pissaloux D; Thomas de Montpreville V; Masliah-Planchon J; Lantuejoul S; Brevet M; Blay JY; Coindre JM; Tirode F; Le Loarer F
    Am J Surg Pathol; 2019 Apr; 43(4):455-465. PubMed ID: 30451731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SMARCA4 inactivation defines a subset of undifferentiated uterine sarcomas with rhabdoid and small cell features and germline mutation association.
    Lin DI; Allen JM; Hecht JL; Killian JK; Ngo NT; Edgerly C; Severson EA; Ali SM; Erlich RL; Ramkissoon SH; Vergilio JA; Ross JS; Elvin JA
    Mod Pathol; 2019 Nov; 32(11):1675-1687. PubMed ID: 31190001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Notable response to nivolumab during the treatment of SMARCA4-deficient thoracic sarcoma: a case report.
    Iijima Y; Sakakibara R; Ishizuka M; Honda T; Shirai T; Okamoto T; Tateishi T; Sakashita H; Tamaoka M; Takemoto A; Kumaki Y; Ikeda S; Miyazaki Y
    Immunotherapy; 2020 Jun; 12(8):563-569. PubMed ID: 32363992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infrequent loss of SMARCA4, SMARCA2, and SMARCB1 expression in uterine mesenchymal tumors.
    Kihara A; Amano Y; Matsubara D; Fukushima N; Fujiwara H; Niki T
    Hum Pathol; 2021 Oct; 116():12-21. PubMed ID: 34271067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thoracic SMARCA4-deficient undifferentiated tumor: current knowledge and future perspectives.
    Shinno Y; Ohe Y;
    Jpn J Clin Oncol; 2024 Mar; 54(3):265-270. PubMed ID: 38117955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SMARCA4-Deficient Thoracic Sarcoma: A Case Report and Review of Literature.
    Stewart BD; Kaye F; Machuca T; Mehta HJ; Mohammed TL; Newsom KJ; Starostik P
    Int J Surg Pathol; 2020 Feb; 28(1):102-108. PubMed ID: 31382829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients with SMARCA4-deficient thoracic sarcoma and severe skeletal-related events.
    Kunimasa K; Nakamura H; Sakai K; Tamiya M; Kimura M; Inoue T; Nishino K; Kuhara H; Nakatsuka SI; Nishio K; Imamura F; Kumagai T
    Lung Cancer; 2019 Jun; 132():59-64. PubMed ID: 31097095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging features of SMARCA4-deficient thoracic sarcomas: a multi-centric study of 21 patients.
    Crombé A; Alberti N; Villard N; Pilleul F; Buy X; Le Loarer F; Kind M
    Eur Radiol; 2019 Sep; 29(9):4730-4741. PubMed ID: 30762113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytology of SMARCA4-Deficient Thoracic Neoplasms: Comparative Analysis of SMARCA4-Deficient Non-Small Cell Lung Carcinomas and SMARCA4-Deficient Thoracic Sarcomas.
    Nambirajan A; Dutta R; Malik PS; Bubendorf L; Jain D
    Acta Cytol; 2021; 65(1):67-74. PubMed ID: 32854100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thorahcic SMARCA4-deficient undifferentiated tumors with ganglioneuroma and enchondroma: implications for SLC7A11 and ARID1A expression: a case report.
    Kito Y; Kawashima K; Saigo C; Hasegawa M; Nomura S; Mikamo T; Hanamatsu Y; Matsuo Y; Takeuchi T
    Diagn Pathol; 2022 Feb; 17(1):29. PubMed ID: 35151345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline mutations of SMARCA4 in small cell carcinoma of the ovary, hypercalcemic type and in SMARCA4-deficient undifferentiated uterine sarcoma: Clinical features of a single family and comparison of large cohorts.
    Connor YD; Miao D; Lin DI; Hayne C; Howitt BE; Dalrymple JL; DeLeonardis KR; Hacker MR; Esselen KM; Shea M
    Gynecol Oncol; 2020 Apr; 157(1):106-114. PubMed ID: 31954538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and management of gastrointestinal SMARCA4-deficient undifferentiated tumors.
    Wang J; Elghawy O; Kurpiel B; Kaur V
    Clin J Gastroenterol; 2023 Dec; 16(6):807-814. PubMed ID: 37651059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.